Get the Stockscreener App
0.3608
11.59%
-0.0473
Cellectar Biosciences Inc Stock (CLRB) Forecast
The Cellectar Biosciences Inc (CLRB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.505, representing a +594.28% increase from the current price of $0.3608. The highest analyst price target is $3.1426, and the lowest is $1.8674.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CLRB Price Target
Average 8.8432
(+2,351% Upside)
Is Cellectar Biosciences Inc (CLRB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 59.91 | Neutral |
| STOCH(9,6) | 49.17 | Neutral |
| STOCHRSI(14) | 44.16 | Neutral |
| MACD(12,26) | 0.0236 | Buy |
| ADX(14) | 28.31 | Buy |
| William %R | -72.96 | Neutral |
| CCI(14) | 141.38 | Buy |
Buy: 3
Sell: 0
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.3037
Buy
|
0.3247
Buy
|
| MA20 |
0.2774
Buy
|
0.2983
Buy
|
| MA50 |
0.2814
Buy
|
0.3002
Buy
|
| MA100 |
0.2894
Buy
|
0.447
Sell
|
| MA200 |
0.9534
Sell
|
0.9789
Sell
|
Buy: 7
Sell: 3
Neutral: 0
Summary: Buy
According to our latest analysis, CLRB could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 3 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on CLRB, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 59.91 indicates that CLRB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 49.17 indicates that CLRB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 44.16 indicates that CLRB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 28.31 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 141.38 indicates that CLRB is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term CLRB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Cellectar Biosciences Inc financial reports and earnings history, Cellectar Biosciences Inc (CLRB) stock could reach $17.46 by 2030, $17.60 by 2040 and $45.19 by 2050. See the projected annual prices until 2050 of the Cellectar Biosciences Inc stock below:
- Cellectar Biosciences Inc (CLRB) is expected to reach an average price of $6.4762 in 2035, with a high prediction of $6.5486 and a low estimate of $6.5462. This indicates an $1,695% rise from the last recorded price of $0.3608.
- Cellectar Biosciences Inc (CLRB) stock is projected to chart a bullish course in 2040, with an average price target of $17.06, representing an $4,628% surge from its current level. The forecast ranges from a conservative $17.18 to a sky-high $17.60.
- Our analysts predict Cellectar Biosciences Inc (CLRB) to jump 7,901% by 2045, soaring from $28.34 to an average price of $28.87, potentially reaching $28.52. While $28.34 is the low estimate, the potential upside is significant.
- Cellectar Biosciences Inc (CLRB) stock is expected to climb by 2050, reaching an average of $44.15, a $12,135% jump from its current level. However, a wide range of estimates exists, with high and low targets of $45.19 and $45.05, respectively, highlighting the market's uncertainty.
Cellectar Biosciences Inc Stock (CLRB) Year by Year Forecast
Cellectar Biosciences Inc Stock (CLRB) Price Forecast for 2025
Cellectar Biosciences Inc Stock (CLRB) is expected to reach an average price of $8.2588 in 2025, with a high prediction of $16.40 and a low estimate of $0.1202. This indicates an +2,189% rise from the last recorded price of $0.3608.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $3.3426 | $1.8674 | $3.1426 | +826.43% |
| August, 2025 | $0.5177 | $1.7177 | $2.1301 | +43.49% |
| September, 2025 | $1.2919 | $1.3929 | $2.0509 | +258.06% |
| October, 2025 | $4.1118 | $2.1367 | $3.0118 | +1,040% |
| November, 2025 | $2.287 | $2.987 | $2.3556 | +533.86% |
| December, 2025 | $3.0059 | $2.5183 | $1.9308 | +733.13% |
Cellectar Biosciences Inc Stock (CLRB) Price Forecast for 2026
The predicted value for Cellectar Biosciences Inc (CLRB) in 2026 is set at an average of $8.2274. Estimates vary from a peak of $16.29 to a trough of $0.1614, indicating an +2,180% surge from the present price of $0.3608.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.8811 | $2.3771 | $2.4373 | +421.37% |
| February, 2026 | $8.3438 | $1.9249 | $10.63 | +2,213% |
| March, 2026 | $6.4686 | $4.10 | $15.60 | +1,693% |
| April, 2026 | $11.55 | $2.889 | $16.29 | +3,101% |
| May, 2026 | $5.5745 | $2.4621 | $11.41 | +1,445% |
| June, 2026 | $1.7993 | $1.4869 | $5.9307 | +398.70% |
| July, 2026 | $0.1804 | $0.4196 | $4.0242 | -50.01% |
| August, 2026 | $1.6052 | $0.2366 | $5.849 | +344.91% |
| September, 2026 | $0.5137 | $0.1614 | $1.8114 | +42.39% |
| October, 2026 | $1.7889 | $1.5451 | $0.9889 | +395.81% |
| November, 2026 | $1.564 | $2.264 | $2.5765 | +333.49% |
| December, 2026 | $2.333 | $1.6078 | $1.483 | +546.62% |
Cellectar Biosciences Inc Stock (CLRB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Cellectar Biosciences Inc (CLRB) is $3.7463, with a high forecast of $4.963 and a low forecast of $2.5295. This indicates an +938.32% increase from the last price of $0.3608.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.2632 | $2.5432 | $2.2268 | +527.26% |
| February, 2027 | $3.4833 | $2.5295 | $2.2353 | +865.44% |
| March, 2027 | $3.8523 | $4.0311 | $3.8647 | +967.70% |
| April, 2027 | $3.5384 | $3.9774 | $3.6961 | +880.72% |
| May, 2027 | $4.5996 | $4.7578 | $4.0438 | +1,175% |
| June, 2027 | $5.3315 | $4.9464 | $4.8777 | +1,378% |
| July, 2027 | $2.9187 | $3.1967 | $4.7653 | +708.95% |
| August, 2027 | $3.6509 | $3.1405 | $2.6749 | +911.88% |
| September, 2027 | $4.8918 | $4.5456 | $4.963 | +1,256% |
| October, 2027 | $5.236 | $5.1784 | $4.957 | +1,351% |
| November, 2027 | $4.3821 | $4.9411 | $4.5173 | +1,115% |
| December, 2027 | $2.6801 | $3.5101 | $4.1409 | +642.81% |
Cellectar Biosciences Inc Stock (CLRB) Price Forecast for 2028
In 2028, Cellectar Biosciences Inc (CLRB) is projected to reach an average price of $4.3469, with a high projection of $5.7234 and a low estimate of $2.9704. This indicates an +1,105% rise from the last price of $0.3608.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.0954 | $2.9704 | $2.8702 | +757.94% |
| February, 2028 | $4.7504 | $3.459 | $3.9904 | +1,217% |
| March, 2028 | $5.8093 | $4.7342 | $5.6855 | +1,510% |
| April, 2028 | $5.6845 | $5.8007 | $5.7169 | +1,476% |
| May, 2028 | $5.7734 | $5.7021 | $5.7234 | +1,500% |
| June, 2028 | $5.5886 | $5.4648 | $5.5372 | +1,449% |
| July, 2028 | $5.1738 | $5.2938 | $5.4324 | +1,334% |
| August, 2028 | $4.9827 | $5.0326 | $5.0613 | +1,281% |
| September, 2028 | $4.9779 | $5.0003 | $4.9141 | +1,280% |
| October, 2028 | $4.683 | $4.723 | $4.8917 | +1,198% |
| November, 2028 | $4.182 | $4.312 | $4.6068 | +1,059% |
| December, 2028 | $3.6871 | $3.8371 | $3.9558 | +921.94% |
Cellectar Biosciences Inc Stock (CLRB) Price Forecast for 2029
The 2029 price forecast for Cellectar Biosciences Inc Stock (CLRB) is $6.3449 on average, with a high prediction of $12.68 and a low estimate of $0.00979. This represents an +1,659% increase from the previous price of $0.3608.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $3.4061 | $3.4495 | $3.6147 | +844.04% |
| February, 2029 | $3.3913 | $3.5313 | $3.4275 | +839.93% |
| March, 2029 | $2.6964 | $2.8626 | $3.205 | +647.34% |
| April, 2029 | $2.0916 | $2.1278 | $2.1702 | +479.70% |
| May, 2029 | $2.4605 | $2.0754 | $2.0147 | +581.96% |
| June, 2029 | $1.6057 | $1.7857 | $2.2043 | +345.03% |
| July, 2029 | $1.1808 | $1.4908 | $1.4695 | +227.28% |
| August, 2029 | $0.2402 | $0.00979 | $0.7102 | -33.42% |
| September, 2029 | $0.1049 | $0.0464 | $0.3964 | -70.91% |
| October, 2029 | $0.8861 | $0.0387 | $1.1737 | +145.59% |
| November, 2029 | $0.0909 | $0.0709 | $1.0984 | -74.79% |
| December, 2029 | $16.08 | $0.0592 | $12.68 | +4,357% |
Cellectar Biosciences Inc Stock (CLRB) Price Forecast for 2030
Cellectar Biosciences Inc Stock (CLRB) is expected to reach an average price of $14.06 in 2030, with a high forecast of $21.11 and a low forecast of $7.0095. This signifies an +3,796% surge from the last price of $0.3608.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $15.72 | $17.23 | $17.46 | +4,256% |
| February, 2030 | $15.87 | $16.58 | $15.37 | +4,298% |
| March, 2030 | $15.47 | $15.52 | $15.36 | +4,187% |
| April, 2030 | $15.47 | $15.58 | $14.77 | +4,187% |
| May, 2030 | $16.01 | $13.97 | $15.01 | +4,337% |
| June, 2030 | $19.93 | $18.69 | $17.77 | +5,424% |
| July, 2030 | $19.79 | $20.53 | $21.11 | +5,386% |
| August, 2030 | $13.65 | $14.55 | $16.76 | +3,682% |
| September, 2030 | $8.2956 | $11.45 | $10.52 | +2,199% |
| October, 2030 | $4.8505 | $7.0095 | $6.5832 | +1,244% |
| November, 2030 | $16.28 | $11.42 | $11.25 | +4,413% |
| December, 2030 | $20.74 | $20.15 | $18.90 | +5,647% |
1.21%
1.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):